Live
FierceBiotechAs Akeso takes center stage at ASCO, China biotech industry cements its coming of ageFierceBiotechIMU Biosciences nabs $53M funding round to ‘decode’ the immune system10x Genomics NewsDeutsche Bank Adjusts Price Target on 10x Genomics to $30 From $23, Maintains Hold Rating - marketscreener.comFierceBiotechAscidian, Lilly ink RNA exon editing pact worth up to $1.9B for genetic kidney diseasesEndpoints NewsLilly strikes Ascidian deal worth up to $1.9B for RNA editing in kidney diseasesBioPharma DiveLilly, Ascidian link up in RNA exon editing pactCellPlant cell wall-plasma membrane attachments mediate stress resilience through cellulose synthase complexes and remorinsCellExplosive cytotoxicity of ruptoblasts bridges hormone surveillance and immune defenseLabiotechSurge in M&As driven by patent expirationsThermo FisherThermo Fisher Scientific Unveils Next-generation Innovations at ASMS 2026 to Accelerate Drug Discovery - BioSpectrum AsiaeLifeHSD17B7 is required for the function of sensory hair cells by regulating cholesterol synthesisBioPharma DiveCelcuity breast cancer drug misses ‘lofty’ expectations in ASCO-spotlighted trial
eLife Mar 4, 2026

Acetylation of H3K115 is associated with fragile nucleosomes at CpG island promoters and active regulatory sites

Acetylation of H3K115 is associated with fragile nucleosomes at CpG island promoters and active regulatory sites

Original
Body unavailable. Use the original source.